Veterinary and Comparative Oncology

Papers
(The median citation count of Veterinary and Comparative Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Issue Information31
Issue Information31
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy18
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy17
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma17
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma15
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours15
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)15
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy13
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours13
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain13
Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD12
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study12
Dose and Duration of Upfront Steroid Administration Have no Prognostic Impact in Dogs With Multicentric Diffuse Large B‐Cell Lymphoma12
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping12
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study12
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review11
Blood biomarkers for canine cancer, from human to veterinary oncology10
Cross‐Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B‐Cell Lymphoma Identifies a Conserved Replication– DNA Damage Mo10
Issue Information10
Issue Information10
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs10
Issue Information10
Issue Information10
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma10
10
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs10
Author Index9
9
Immunophenotyping and Mutation Analysis of Canine Intestinal T‐Cell Lymphoma: A Comparative Pathological Study of Human Enteropathy‐Associated T‐Cell Lymphoma9
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs9
Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma9
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas9
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells9
Issue Information8
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma8
Frontal sinus carcinoma in forty‐one dogs (2001–2022)8
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs8
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain8
8
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs8
8
Author Index7
7
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma7
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Eq7
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma7
7
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma6
Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma6
Favourable Prognostic Significance of HER2 Mutations in Canine Pulmonary Adenocarcinoma Following 6
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study6
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma6
Comparison of the anticancer effects of various statins on canine oral melanoma cells6
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk6
Critical Questions in Genomic Diagnostics for Veterinary Oncology: What We Need to Know6
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance6
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire6
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis6
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment6
6
5
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells5
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study5
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study5
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases5
Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours5
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs5
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases5
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience5
Rescue Protocols for Canine Non‐Indolent B Cell Lymphoma: A Systematic Review5
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade4
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases4
Comparative Response of Canine and Human Osteosarcoma Tumour Cell Lines to Molecularly Targeted Anticancer Agents at Clinically Relevant Exposures With Analysis of Genomic Biomarkers4
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study4
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy4
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma4
VCS abstract4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission4
Machine Learning‐Based Risk Prediction for Feline Mammary Tumours: A Comprehensive Epidemiological Analysis Using Multi‐Model Ensemble Approach4
Issue Information4
Proteasome Inhibitor–Induced Cytotoxic Mechanisms in Canine Pulmonary Adenocarcinoma Cell Lines4
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes4
Correction to “ DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Ti4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours4
A Multi‐Institutional Retrospective Study of 21 Dogs Having Undergone Hypofractionated Radiotherapy for Adrenal Tumours (2017–2024)4
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells4
The animal's microbiome and cancer: A translational perspective4
Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study3
3
VCS 2024 Abstracts3
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration3
Cover Image3
Correction to: Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria3
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour3
Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString‐Based Urine Assay3
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?3
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies3
Issue Information3
Issue Information3
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease3
Early‐Delayed Radiotoxicity Associated With Stereotactic Radiation Therapy Following a Daily 6 Gy × 5 (30 Gy) Protocol for Presumed Canine Intracranial Meningiomas3
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma3
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway3
Prognostic Impact of CD206 + M2 ‐Like Macrophages in Canine Appendicular Osteosarcoma3
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey3
One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas3
2
2
Outcome and Prognostic Factors of Dogs Treated for Infiltrative Lipoma Undergoing Radiation Therapy: A Retrospective Multi‐Institutional Study of 29 Cases2
Issue Information2
Sequence Diversity and Expression Profiles of T Cell Receptor Beta Chain Constant Genes TRBC1 and 2
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases2
Issue Information2
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)2
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy2
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours2
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma2
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma2
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours2
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study2
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs2
Serum Symmetric Dimethylarginine as a Predictor of Toxicity of Carboplatin in Dogs2
Polarisation‐Sensitive Optical Coherence Tomography for Surgical Margin Evaluation and Diagnosis of Excised Canine Cutaneous and Subcutaneous Tumours2
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats2
Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment2
Investigation of a 4.3 Gy × 10‐Fraction Volumetric Modulated Arc Therapy Protocol for Canine Prostatic Carcinoma: A Normal Tissue Complication Probability Study2
2
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma2
Tolerability and Adverse Event Profile of Fixed Dose Rate Gemcitabine in Dogs With Neoplasia2
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus2
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy2
Precision in Parsing: Evaluation of an Open‐Source Named Entity Recognizer (NER) in Veterinary Oncology2
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours2
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma2
Comparison of Morbidity Between Sentinel Lymph Node Biopsy and Elective Neck Dissection in Dogs With Head and Neck Malignancies2
Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer2
2
Impact of palliative‐intent radiotherapy with or without chemotherapy on lameness in flat coat retrievers with localised periarticular histiocytic sarcoma – a retrospective cohort, single institution 2
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma2
Whole Exome Sequencing of Feline Oral Squamous Cell Carcinoma Reveals Genomic Parallels With Human Head and Neck Squamous Cell Carcinoma2
Prognostic Impact of Mast Cell Infiltration Detected by Flow Cytometry on Excised Sentinel Lymph Nodes in Dogs With Newly Diagnosed Mast Cell Tumours2
Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma1
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study1
Issue Information1
A multi‐centre prospective evaluation of internet research habits among owners seeing a veterinary oncologist1
Issue Information1
Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022)1
Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis1
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases1
Comparison of Volumetric Modulated Arc Therapy and Fixed‐Field Intensity‐Modulated Radiotherapy for Canine Prostatic Carcinoma Using a 4.3 Gy × 10‐Fraction Protocol: A Dosimetric Planning Study1
Evaluating the Impact of Elective Nodal Irradiation for Dogs With Oral Malignant Melanoma Undergoing Hypofractionated Radiotherapy1
1
Chemical Exposures, DNA Methylation and Whole Blood DNA Damage in Pet Golden Retrievers1
1
Cytokine‐Enhanced Vaccine as Surgery Adjuvant Treatment for Spontaneous Canine Melanoma: Comparison of Two Intralesional Procedures for Local Disease Control1
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma1
Clinical Efficacy and Tolerability of Sorafenib in Dogs With Advanced Carcinomas1
Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or ‘UC or not UC – that is the question’1
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment1
Recurrence Rates for Mandibular Fibrosarcoma Associated With Mandibular Canal Invasion Following Mandibulectomy Procedures in Dogs1
Lymphotropic nanoparticle magnetic resonance imaging for diagnosing metastatic lymph nodes in dogs with malignant head and neck tumours1
Immunohistochemical Expression of Programmed Death‐Ligand 1 and Cytotoxic T‐Lymphocyte Antigen‐4 in Canine Cutaneous Mast Cell Tumours1
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs1
Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma1
Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma1
Preoperative Computed Tomography Features as Predictors of Malignancy and Survival in Canine Adrenal Tumours1
Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024)1
Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy1
1
Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria1
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine1
Editorial1
Hemangiosarcoma: A Systematic Review of Biomarkers in Diagnosis, Prognosis, and Therapeutic Strategies1
Issue Information1
Auranofin Suppresses the Growth of Canine Mammary Tumour Cells and Induces Apoptosis via the PI3K/AKT Pathway1
Local tumour nanoparticle thermal therapy: A promising immunomodulatory treatment for canine cancer1
Chemoresistance Cytological Score for Canine Transmissible Venereal Tumour: A Proposed System of Predicting Vincristine Resistance1
Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs1
Tissue Proteomics of Feline Mammary Carcinoma: Differences in Protein Profiles Among Histological Grades Using Liquid Chromatography–Tandem Mass Spectrometry1
Issue Information1
1
Issue Information1
Transferrin Receptor‐1: Expression in Canine Mammary Tumours and In Vitro Therapeutic Applications1
Messenger RNA From Canine Cytology Lymph Node Specimens Can Be Utilised for Gene Expression Profiling Using Digital RNA1
0.19454503059387